Skip to content
Artwork for Simply Oncology
Health & FitnessMedicineEducationScienceLife Sciences

Simply Oncology

John McGrane & Michael Rowe

Welcome to Simply Oncology. 
Cancer is daunting for both patients and for clinical teams.
Dr John McGrane and Dr Michael Rowe are oncologists who want to break down the complex parts of cancer care into clear and simple sessions.
We will dive deep into the world of cancer research, patient stories and the latest cancer breakthroughs. 
Simply Oncology will have patient focused episodes along with episodes that allow anyone with an interest in oncology to stay up to date.

We hope you join us as we unpick all parts of cancer. 

John & Mike

Play
  • 36 episodes
  • weekly
  • Avg 27 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Friday · 29 min

    Episode 129: Can we change Multi Disciplinary Team meetings for the better? With Dr Nicky Thorp

    Send us Fan Mail 🎙️Join us as we return to complete our 2 part look at Multi Disciplinary Team meetings (Tumor Boards). In our last episode we set the scene as to why they were set up. 🎙️In this episode we return with the wonderful Dr Nicky Thorp, consultant oncologist and Vice President of the Royal College of Radiologists. 🎙️Nicky has been leading a review of the MDT process to see if we can make them as good as possible. Can we get the most out of these meetings to maximise outcomes for our patients. They were designed to get the Lone Wolf running with the Pack🐺 Can we get the Pack running in the right direction🐺🐺🐺? Could Asynchronous MDTs work? Can we combine the talents of the many groups looking at optimising MDTs? Much to discuss🤔 Enjoy

    • Transcript
  • November 13 · 27 min

    Episode 128: How do we make the most of our Multi-Disciplinary Team meetings (Tumor Boards) with Dr Nicky Thorp?

    Send us Fan Mail Join us as we discuss MDTs in this weeks episode! Love them or hate them we are all part of cancer Multi-Disciplinary Team meetings (Tumor Boards). Why did they start? How have they improved cancer care? Are they a delay to decisions? If MDT is More Dull Tedium rather than Make Dynamic Treatments then this episode is for you!! We talk to the wonderful Dr Nicky Thorp, consultant oncologist and vice president of the Royal College of Radiologists who has been part a programme to try and review MDTS. A great episode that affect anyone in cancer care. Enjoy!

    • Transcript
  • November 6 · 37 min

    Episode 127: In the Clinic - Beyond targeted therapy in lung cancer with Dr Tom Newsom-Davis

    Send us Fan Mail Join us as we explore recent advances in lung cancer with the excellent Dr Tom Newsom-Davis. Tom is a very welcome returning guest. He is the current Chair of BTOG - British Thoracic Oncology Group - and a medical oncologist specialising in lung cancer at the Chelsea & Westminster Hospital, London. Tom is a superb speaker on the topic of lung cancer and he guides us through: - Antibody drug conjugates - T cell engagers - Tarlatumab - Bi specifics and Tri specifics Tom breaks the record for the amount of Toxic Payload namedrops for ADCs. The future of lung cancer remains hugely exciting! Enjoy

    • Transcript
  • November 1 · 26 min

    Episode 126: In the Clinic - Peri-operative therapy in Colon Cancer with Professor Jenny Seligmann (part2)

    Send us Fan Mail Welcome to the second part in of the Simply Oncology podcast, looking at perioperative colon cancer therapy. We are back with the wonderful Professor Jenny Seligman from Leeds, St. James's Cancer Hospital. In our last episode we looked at the series of FOXTROT trials and their impact in the colon cancer peri-op space. In this next episode we look at the ARIEL trials. We have a clear signal in the MMR deficient patient group. We also look at where the MMR proficient patient group may benefit. All this and Jenny keeps us in our place throughout. Enjoy!

    • Transcript
  • October 16 · 24 min

    Episode 124: Real World Evidence lessons in Kidney Cancer with Professor Daniel Heng

    Send us Fan Mail 🎙️Join us as we finish our discussion through Kidney Cancer with the wonderful Professor Daniel Heng of Calgary,Canada🇨🇦 🎙️In this episode we focus on the Real World Evidence 🌎🔎 from the IMDC 🎙️what cane we learn from comparing complete response rates and durable responses between IO-IO therapy and IO-VEGF therapy🤔 🎙️What has Danny learned through setting up the IMDC and how to bring people with you? 🎙️What areas does Danny think need expanding in the future in Renal Cancer? All this and more alongside some genuine laughter 😂with Danny Enjoy!!!

    • Transcript
  • October 9 · 26 min

    Episode 123: The Big IMDC Kidney Cancer episode with Professor Daniel Heng

    Send us Fan Mail 🚨Join us today as we discuss all things kidney cancer !! 💥We are Hanging with the Heng! The legend that is Professor Daniel Heng (AKA DannyHeng tm) from The Albert Child Cancer Centre, Calgary, Canada🇨🇦 🎙️We hear how Danny Heng started the IMDC (International Metastatic renal cell carcinoma Database Consortium) prognostic score in advanced kidney cancer. 🎙️We discuss how the IMDC moved as prognostic score to then being part of stratification for modern metastatic kidney cancer trials. 🎙️IMDC now shapes what drugs we give for 1st line metastatic kidney cancer. 🙌🏽Kidney cancer survivals have quadrupled since the early Interferon era 💡We discuss biomarkers 🧭 💡We discuss more biomarkers - KIM 1, Clusters, Composite Biomarkers. This was so much fun to record and an absolute privilege to have Danny on the Podcast🙌🏽 ☀️ Enjoy ☀️

    • Transcript
  • October 2 · 26 min

    Episode 122: In the Clinic - Scoping Acute Oncology services in the future with Dr Caroline Wilson

    Send us Fan Mail Join us as we complete our discussion on all things Acute Oncology Services with the superb Dr Caroline Wilson PhD FRCP from the The Christie NHS Foundation Trust. 🎙️We look at what future directions AOS will move into and what the challenges may be. 🎙️What are the BIG 5 AOS presentations? 🎙️Caroline stakes a claim for the need to change how we view the role of who manages acute oncology toxicities. Enjoy

    • Transcript
  • September 25 · 27 min

    Episode 121: In the Clinic - The Acute Oncology Service - Cancer's Front Door Heroes with Dr Caroline Wilson

    Send us Fan Mail Welcome back - today we are discussing Acute Oncology Services and how they have evolved over the last 15 years. Why were they set up ? To give cancer patients support and care when they need it most - when they are admitted to hospital with problems. Do you know your type 1 from your type 2 or 3 Acute oncology patient? We talk all things AOS with the wonderful Dr Caroline Wilson from The Christie Hospital in Manchester. What would your ideal Acute Oncology Service look like? Caroline tells us how she is building her new service. Is yours the same as ours - probably not? Do we need to loosen the oncology strings on SACT toxicity and encourage this to be a general medical issue. All this and more - Enjoy!

    • Transcript
  • September 18 · 22 min

    Episode 120: In the Clinic: Part 2 of the INTENSIFY trial with Professor Simon Crabb and Dr Sarah Chamberlain

    Send us Fan Mail Welcome back to part 2 of our 2 part special on the INTENSIFY trail in metastatic prostate cancer study. We welcome back the wonder Professor Simon Crabb and Dr Sarah Chamberlain from the University Hospital Southampton where they work n the medical oncology department treating urological cancers. If you haven’t listened to part 1 please go check it out now where we set the foundations of the INTENSIFY trial. Now lets get in to the science behind the INTENSIFY study looking at eh DECIPHER score and pTEN.

    • Transcript
  • September 11 · 21 min

    Episode 119: In the Clinic - Discussing the INTENSIFY trial in metastatic prostate cancer with Professor Simon Crabb and Dr Sarah Chamberlain

    Send us Fan Mail Welcome to the Simply Oncology Podcast. Today we are focusing in on the prostate cancer trial called INTENSIFY. This is a trial where we will look at intensifying metastatic prostate cancer patients. Those patients established on combination LHRHa and ARPi therapy could then be randomised at 6months to adding chemotherapy or not if they don't have an optimal PSA tumour marker improvement. We have brought the wonderful Professor Simon Crabb, and Dr Sarah Chamberlain from the oncology team at Southampton. They are part of the leadership team for the trial. This trial is already running in some centres and we discuss why it is happening and how it would be delivered.

    • Transcript
  • September 4 · 20 min

    Episode 118: Levelling the playing field in MIBC with Dr Mohini Varughese

    Send us Fan Mail Welcome back to part 2 of this episode on radiotherapy in muscle invasive bladder cancer where we explore the challenging questions of equitable access to neoadjuvant and adjuvant novel therapies in patients not suitable for cystectomy. We welcome back the brilliant Dr Mohini Varughese, fighting the good fight for bladder preservation treatment!

  • August 28 · 27 min

    Episode 117: Bladder cancer- Systemic therapy and Radiotherapy with Dr Mohini Varughese

    Send us Fan Mail Welcome back! 🎙️We dive back in to the exciting and dynamic world of systemic therapy in localised muscle invasive bladder cancer 🔦Shining a spotlight on bladder preservation treatment ie: radiotherapy with a radiosensitiser, a key player in the curative treatment of this cancer. 🤷Is Radiotherapy at risk of being left behind with recent trials improving neoadjuvant and adjuvant systemic therapies with trials that have focussed exclusively on cystectomy. 🎙️We welcome back Dr Mohini Varughese from Royal Devon University Hospitals to take on this important topic in a 2 part episode! 🎙️What is the Real World Landscape like and how many people are having radiotherapy for muscle invasive bladder cancer?? All this and more!

  • August 21 · 26 min

    Episode 116: Fundamentals - Nutrition in Cancer - Tackling the Myths with Chloe Nottingham, Dietitian

    Send us Fan Mail 🎙️Join us as we return with the excellent Chloe Nottingham to tackle some cancer diet myths. ❌Fasting ❌Alkali diets ❌No sugar diets 🥗Every year there is a new ‘Must Try’ diet to control your cancer. 🔎We look at the Social Media impact on what cancer patients are eating and the potential pitfalls of that. ‼️Nearly 40% of patients are following diet advice from social media that could be doing them harm!! 🤔Does a clever meme make you a good source of safe info??? 😫We also look at the ‘Feeding Pressure’ that some patients feel from loved ones who are trying their best to help. 🎙️Chloe talks so much sense we almost think it should be on another podcast!!! 👍Dietitians are an amazing resource to help support patients support themselves. 🥗Healthy eating 🍎alongside exercise 🏃‍♂️remain the best platform for a body to tackle cancer. 📢A must listen for anyone tackling cancer or their loved one. Enjoy and share!!!

    • Transcript
  • August 14 · 25 min

    Episode 115: Fundamentals - Nutrition in Cancer with Chloe Nottingham, Dietitian Part 1

    Send us Fan Mail We are what we eat. Join us as we discuss with the excellent Chloe Nottingham, a specialist cancer dietitian with years of experience. Malnutrition can lead to worse outcomes in cancer care. Depending on the cancer type between 40-80% of patients suffer from malnutrition. Why is that so important; - Lower treatment tolerance - Lower treatment completion and doses - More delays getting onto treatment - Lower survival rates - Reduced wellbeing and energy - Longer hospital stays Getting good nutrition support and eating well can massively impact your cancer journey. If food was a drug we would pay a fortune for it !!!! Chloe helps us plan a route to healthy and sensible ways of keeping our body weight and muscles working. Enjoy!!!

    • Transcript
  • August 7 · 29 min

    Episode 114: Testosterone replacement therapy in Prostate cancer with Dr Samantha Strumeier

    Send us Fan Mail Welcome back for our second of this 2 part special on testosterone in cancer with the excellent Dr Samantha Strumeier from Barts health NHS trust. Did you know that 10% of patients can end up with ongoing testosterone suppression after completing a course of androgen deprivation therapy. How do we tackle theses cases? What is the evidence. Sam marks john's strategy out of 10 with surprising results.

  • July 31 · 29 min

    Episode 113: In the Clinic - Managing Low Testosterone in Cancer with Dr Samantha Strumeier

    Send us Fan Mail Join us as we cover the effect of cancer and its treatment on Testosterone levels in cancer. We are joined by the amazing Samantha Strumeier, nurse consultant and nursing lead for urological cancers at St Barts Hospital London. Having experience in testosterone replacement therapy at Memorial Sloane Kettering Hospital New York she shares this with us and what she is doing now. We explore the impact of low testosterone in men on cancer treatment. One major area where this impacts the most is prostate cancer where we cause low testosterone with androgen deprivation therapy. What happens if testosterone stays low after the treatment finishes. We set the scene for how we can help patients with low testosterone. All this and Samantha tries not to be too disappointed by Mike and John!!!

    • Transcript
  • July 24 · 26 min

    Episode 112: Prostate Cancer, Exercise and lifestyle with Dr Lucy Gossage

    Send us Fan Mail Lifestyle and patient choices in Prostate Cancer Prostate cancer has been part of a revolution in terms of treatment options and improved outcomes for our patients. How can we make that improvement in numbers on survival curves match the goals and needs of our patients? Join us in this second of 2 special live episodes of the Simply Oncology Podcast on Patient Choices and Lifestyle in Prostate Cancer. We talk to patient expert Tony Collier, Dr Lucy Gossage - an oncologist involved with Move Against Cancer and Professor Alison Birtle an oncologist with extensive experience treating prostate cancer. In this Episode we focus on Dr Lucy Gossage and her experience of supporting cancer. patients through exercise Lucy Gossage has a background in international level sport alongside being an oncologist, so it seemed natural for her to be involved in Move Against Cancer. We discuss the massive positive steps that giving patients permission to move and exercise can have for their health -both physical and mental. Recapturing some normality amongst the backdrop of cancer and its treatment can only be a good thing for patients. We hear about the huge positive impact that maintaining exercise has had on Tony’s life with cancer. We hope you enjoy! *This is a non-promotional podcast episode organised by Bayer PLC in partnership with Simply Oncology (Dr John McGrane and Dr Michael Rowe) to highlight the importance of holistic care in managing patients with prostate cancer. Bayer provided honoraria to the speakers of this podcast. The views and opinions expressed are those of the speakers and do not necessarily reflect those of Bayer PLC or Simply Oncology. This content is for educational purposes only and should not replace clinical judgement.*

  • July 17 · 34 min

    Episode 111: Prostate Cancer through a patient Lens with Tony Collier BEM

    Send us Fan Mail Lifestyle and patient choices in Prostate Cancer Prostate cancer has been part of a revolution in terms of treatment options and improved outcomes for our patients. How can we make that improvement in numbers on survival curves match the goals and needs of our patients? Join us in this first of 2 special live episodes of the Simply Oncology Podcast on Patient Choices and Lifestyle in Prostate Cancer. We talk to patient expert Tony Collier, Dr Lucy Gossage - an oncologist involved with Move Against Cancer and Professor Alison Birtle an oncologist with extensive experience treating prostate cancer. In this Episode we talk to Tony Collier about his experience of being a prostate cancer patient. We hear how the focus on treatment led him to have to advocate his quality of life and life goals himself. We hear how clinicians could align with patients’ goals with just a few simple questions. We hear about the huge positive impact that maintaining exercise has had on Tony’s life with cancer. Hearing Tony’s live experience of some very personal aspects of a cancer diagnosis and treatment is hugely moving and powerful. We hope you enjoy! *This is a non-promotional podcast episode organised by Bayer PLC in partnership with Simply Oncology (Dr John McGrane and Dr Michael Rowe) to highlight the importance of holistic care in managing patients with prostate cancer. Bayer provided honoraria to the speakers of this podcast. The views and opinions expressed are those of the speakers and do not necessarily reflect those of Bayer PLC or Simply Oncology. This content is for educational purposes only and should not replace clinical judgement.*

  • July 10 · 21 min

    Episode 110: Part 2 of Managing Menopause in Gynaecological Cancers with Dr Shibani Nicum

    Send us Fan Mail Join us as we finish our discussion on managing menopause in gynaecological cancers with the wonderful Shibani Nicum. Shibani works as as Associate Professor in Medical oncology treating gynaecological cancers at UCL Hospitals London. Shibani helped se up the meno.pause app in conjunction with the British Menopause Society to help guide clinical teams to support patients with menopause issues as part of their gynae cancer treatment. We look at setting up a complex menopause MDT and what lifestyle factors can help in this setting. As we see ongoing improvements in survival outcomes maintaining quality of life is so important and managing menopausal issue is a big part of that quality of life. Enjoy

Showing 1–20 of 36 episodes